Document is current

Any future updates will be listed below

Extended single-dose toxicity study of [211At]meta-astatobenzylguanidine in normal mice in preparation for the first-in-human clinical trial of targeted alpha therapy for pheochromocytoma and paraganglioma

Crossref DOI link: https://doi.org/10.1007/s12149-025-02065-0

Published Online: 2025-06-18

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark